Answers are grounded in this paper and cite their sources.
There is substantial underrepresentation of patients 65 years of age or older in studies of treatment for cancer. The reasons should be clarified, and policies adopted to correct this underrepresentation.
No takes yet. Share an insight, caveat, or question.
Hutchins et al. (1999) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: